• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

21.98 +0.46 (+2.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amphastar Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stands Out as a Quality Investing Candidate ↗
August 15, 2026
Via Chartmill
News headline image
Amphastar (AMPH) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
New product launches drove 5% revenue growth and margin expansion. 
Via The Motley Fool
Topics Earnings
News headline image
The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call
August 13, 2026
Amphastar Pharmaceuticals delivered results in Q2 that surpassed Wall Street expectations, reflecting continued strength across its diversified product portf... 
Via StockStory
Topics Earnings
News headline image
AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results
August 07, 2026
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 5.4% year on y... 
Via StockStory
Amphastar Pharmaceuticals (NASDAQ:AMPH) Beats Q2 Earnings Estimates, Shares Rise After Hours ↗
August 06, 2026
Via Chartmill
Amphastar Pharmaceuticals (NASDAQ:AMPH) Screens as a High-Quality Stock with Deep Value Appeal ↗
July 18, 2026
Via Chartmill
Amphastar (AMPH) Q1 2026 Earnings Transcript ↗
May 07, 2026
Via The Motley Fool
News headline image
Amphastar Pharmaceuticals Q2 Earnings Call Highlights ↗
August 06, 2026
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported second-quarter 2026 revenue growth, supported by recently launched products including ipratropium bromide inhalation, while management said it is... 
Via MarketBeat
Topics Earnings
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026
August 06, 2026
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 5.4% year o... 
Via StockStory
News headline image
What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings
August 04, 2026
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) will be reporting results this Thursday after market hours. Here’s what to look for. Amphastar ... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Value Stock to Own for Decades and 2 Facing Challenges
August 03, 2026
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the... 
Via StockStory
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 Results Miss Estimates, Stock Slides After Hours ↗
May 07, 2026
Via Chartmill
News headline image
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds
July 28, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
3 Reasons AMPH is Risky and 1 Stock to Buy Instead
July 28, 2026
Amphastar Pharmaceuticals has gotten torched over the last six months - since January 2026, its stock price has dropped 27.6% to $18.92 per share. This was p... 
Via StockStory
Topics Supply Chain
News headline image
3 Stocks Under $50 We Keep Off Our Radar
July 22, 2026
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However... 
Via StockStory
Topics Energy
News headline image
1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges
July 10, 2026
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
June 12, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
Topics Artificial Intelligence
News headline image
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth ↗
June 10, 2026
Amphastar Pharmaceuticals (NASDAQ:AMPH) is positioning itself for a broader shift from complex generics toward proprietary medicines and biosimilars, Chief Financial Officer and Executive Vice... 
Via MarketBeat
News headline image
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag ↗
June 04, 2026
Amphastar Pharmaceuticals (NASDAQ:AMPH) executives told investors at the Jefferies Healthcare Conference that the company is maintaining expectations for mid- to high-single-digit revenue growth in... 
Via MarketBeat
News headline image
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
May 27, 2026
Via ACCESS Newswire
News headline image
3 Stocks Under $50 with Open Questions
May 26, 2026
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However... 
Via StockStory
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
May 14, 2026
What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 2.8% in the morning session after Wells Fargo downgraded the comp... 
Via StockStory
News headline image
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook ↗
May 14, 2026
Amphastar Pharmaceuticals (NASDAQ:AMPH) executives said the company is taking steps to address rebate and discounting pressure on BAQSIMI while maintaining its full-year revenue outlook, according to... 
Via MarketBeat
News headline image
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call
May 14, 2026
Amphastar Pharmaceuticals’ first quarter was marked by flat revenue and a significant shortfall in non-GAAP profit compared to analyst expectations, promptin... 
Via StockStory
Topics Earnings
News headline image
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment
May 12, 2026
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops
May 07, 2026
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) missed Wall Street’s revenue expectations in Q1 CY2026, with sales flat year on year at $171.2 ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
May 07, 2026
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
May 06, 2026
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect
May 05, 2026
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) will be announcing earnings results this Thursday after market hours. Here’s what investors sho... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down
May 04, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap